Assyro AI

Orange Book product · Generic (ANDA)

NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE

NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE

Generic (ANDA)ANDA 076518OTC PERRIGO

At a glance

Mar 17, 2004

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Mar 17, 2004

    22 yr 7 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE

Strength

220MG;120MG

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

TE code

Not listed

Application

ANDA 076518

Product number

001

Marketing status

OTC

Reference listed drug (RLD)

No

Reference standard (RS)

Yes

Active-ingredient family

View full family

Generic (ANDA) of NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.